Sugi Predict

Sugi Predict / Compounds / SCHEMBL913050

SCHEMBL913050

SCHEMBL913050

CN1CCN(C(=O)Nc2cccc(Nc3ncc(C(N)=O)c(NCc4ccccc4)n3)c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ STAT6 P42226 11/20 0.69
▸ SYK P43405 1/20 0.62
▸ NTRK1 P04629 3/20 0.57
▸ BMPR2 Q13873 2/20 0.57
▸ TBK1 Q9UHD2 2/20 0.57
▸ NUAK1 O60285 1/20 0.57
▸ STK16 O75716 1/20 0.57
▸ CSNK2A2 P19784 1/20 0.57
▸ TYK2 P29597 1/20 0.57
▸ AAK1 Q2M2I8 1/20 0.57
▸ NUAK2 Q9H093 1/20 0.57
▸ MKNK2 Q9HBH9 1/20 0.57
▸ BMP2K Q9NSY1 1/20 0.57
▸ JAK3 P52333 4/20 0.54
▸ JAK2 O60674 3/20 0.54
▸ JAK1 P23458 2/20 0.54
▸ EGFR P00533 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL913548 0.92 STAT6 (0.67) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL913657 0.92 STAT6 (0.65) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL912281 0.92 NTRK1 (0.64) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL3723031 0.92 JAK3 (0.58) STAT6SYKTBK1JAK3JAK2
SCHEMBL914035 0.91 STAT6 (0.68) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL915060 0.90 STAT6 (0.70) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL914883 0.89 STAT6 (0.60) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL912914 0.86 STAT6 (0.59) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL913031 0.86 STAT6 (0.59) STAT6SYKNTRK1BMPR2TBK1
SCHEMBL912915 0.86 STAT6 (0.59) STAT6SYKNTRK1BMPR2TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130137673-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 — — US claimed
US-20110005947-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2011-01-13 — — US claimed
US-8853230-B2 Inhibitors of JAK PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-07 — — US disclosed
US-8853230-B2 Inhibitors of JAK PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-07 — — US disclosed
US-20130137673-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 — — US disclosed
US-20130137673-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 — — US disclosed
US-8367689-B2 Inhibitors of JAK PORTOLA PHARMACEUTICALS, INC. (US) 2013-02-05 — — US disclosed
US-8367689-B2 Inhibitors of JAK PORTOLA PHARMACEUTICALS, INC. (US) 2013-02-05 — — US disclosed
US-20110005947-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2011-01-13 — — US disclosed
US-20110005947-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2011-01-13 — — US disclosed
WO-2010129802-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2010-11-11 — — WO disclosed
WO-2010129802-A1 INHIBITORS OF JAK PORTOLA PHARMACEUTICALS, INC. (US) 2010-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137673-A1 INHIBITORS OF JAK JAK1, JAK2, JAK3 STAT6 16/4885SYK 72/4885NTRK1 3318/4885
US-20110005947-A1 INHIBITORS OF JAK JAK1, JAK2, JAK3 STAT6 16/4885SYK 72/4885NTRK1 3318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.